Dr Payal suicide case: Mumbai doctor murdered, says lawyer after autopsy report

Agencies
May 30, 2019

Mumbai, May 30: The post-mortem report of postgraduate medical student doctor Payal Tadavi, who was found dead in her hostel room recently, has revealed evidence of a ligature mark on her neck.

Under ''provisional cause of death'', the post-mortem report stated ''evidence of ligature mark over neck.''

A Mumbai court on Wednesday sent all the three accused in the case to two-day police custody as her family sought directions for the crime to be treated as a murder.

The lawyer representing Payal Tadvi's family told the court that said that circumstances of the medical post-graduate student's death suggested it was a murder case.

"From the circumstances of her death and bruise mark on her body, we can say that it must be a case of murder and not of suicide. Police must investigate this case in the lines of a murder investigation. Police should be given 14 days time for that," Nitin Satpute, counsel representing the deceased's family, said.

"The accused had taken her body to some other place and later it was brought to hospital so there is a suspicion of tampering with the evidence," Satpute alleged in court.

The matter was being heard before magistrate RM Sadrani of a Mumbai sessions court.

Seeking the maximum custody of 14 days, prosecutor Jay Singh Desai told the magistrate that the witnesses are under pressure.

"The accused are superior to almost every witness in the case. Witnesses are afraid of the accused to give their statement. This case may create social unrest if not investigated properly. The police have to retrieve WhatsApp communication from the phones of the accused," Desai argued.

In defence, the lawyers representing the accused dismissed the charge of abetment of suicide and told the court that the three were not aware of Tadvi's caste.

Responding to the request of treating the case as a murder, accused Bhakti Mehre's counsel Sandip Bali said, "As the intervener claimed that this is a murder case, I will emphasize that let all medical reports come in."

Mehre's lawyer also contended that the abetment of suicide charge, saying that it is only based on the statement of Tadvi's mother and is not supported by any other proof.

Advocate Abad Ponda, appearing for accused Hema Ahuja and Ankita Khandelwal, rubbished the claims that the deceased was harassed on the basis of her social identity. "Accused were not aware that the deceased got admission under any quota so they did not know her caste," he argued.

The accused, Ankita Khandelwal, Bhakti Mehre and Hema Ahuja, were arrested for allegedly abetting the post-graduate medical student Dr Tadvi, who belonged to the Scheduled Tribe community, to end her life at her hostel in BYL Nair Hospital on May 22.

The hospital administration had formed an anti-ragging committee to probe the case.

The Maharashtra Association of Resident Doctors (MARD) had suspended the three doctors, who on Monday, wrote to the association urging for a fair probe.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 21,2020

New Delhi, Jul 21: With a spike of 37,148 cases and 587 deaths reported in India in the last 24 hours, the total number of COVID-19 cases stands at 11,55,191, according to the Union Ministry of Health and Family Welfare.

The total number of cases include 4,02,529 active cases, 7,24,578 cured/discharged/migrated and 28,084 deaths, the ministry informed.

Maharashtra remains the worst affected state with 3,18,695 cases and 12,030 deaths.
The second worst-hit state, Tamil Nadu has reported 1,75,678 COVID-19 cases so far while Delhi has reported 1,23,747 cases, according to the Health Ministry.

Meanwhile, as per the information provided by the Indian Council of Medical Research (ICMR), 1,43,81,303 samples have been tested for COVID-19 up to July 20. Of these 3,33,395 were tested yesterday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

London, Mar 4: The UK government has reiterated its concern over the potential impact of the Citizenship Amendment Act (CAA) and said it is continuing to follow the events in India closely.

In response to an urgent question on “Recent Violence in India” tabled by Pakistani-origin Opposition Labour Party MP Khalid Mahmood in the House of Commons on Tuesday, UK’s Minister of State in the Foreign and Commonwealth Office (FCO) Nigel Adams said the UK engages with India at all levels, including on human rights, and also referred to the country's "proud history" of inclusive government and religious tolerance.

"The UK government also have concerns about the potential impact of the legislation (CAA),” said Adams, the Minister for Asia who was standing in for UK Foreign Secretary Dominic Raab, who is on a visit to Turkey.

"It is because of our close relationship with the government of India that we are able to discuss difficult issues with them and make clear our concerns where we have them, including on the rights of minorities. We will continue to follow events closely and to raise our concerns when we have with them,” said the minister.

While Mahmood, who had tabled the urgent question for an FCO statement, described the government response as “facile”, another Pakistani-origin MP Nusrat Ghani called on the government to relay the UK Parliament's concerns to the Indian authorities.

British Sikh Labour MP Tanmanjeet Singh Dhesi said the violence had brought back “painful personal memories” from the 1984 Sikh riots while he was studying in India and fellow Sikh MP Preet Kaur Gill also referenced 1984 in her intervention.

Other MPs sought to highlight the steps taken by the Indian authorities to restore “peace and tranquillity” in Delhi.

“He will be aware that it is not just Muslims who have been killed; Hindus have also been killed as part of the riots,” said Conservative Party MP Bob Blackman.

Scottish National Party (SNP) MP Alyn Smith sought the UK government’s intervention to share best practice around countering the online disinformation campaign being used in India to “inflame tensions”.

“We are in constant contact on these issues, and we know how important this is to Members of Parliament and their constituents, who may have family in the area,” said Adams, in his response.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.